Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fresenius Kabi USA LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013548
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable and specialty pharmaceutical products, transfusion technologies, parenteral nutrition and enteral nutrition. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Fresenius Kabi USA LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Licensing Agreements 13
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 13
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 14
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 15
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 16
Fresenius Kabi USA LLC – Key Competitors 17
Fresenius Kabi USA LLC – Key Employees 18
Fresenius Kabi USA LLC – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Strategy And Business Planning 21
Nov 21, 2017: Fresenius Kabi to Expand Pharmaceutical Manufacturing in North Carolina 21
Sep 21, 2017: Fresenius Kabi breaks ground for $250 million manufacturing campus in Chicago 23
Legal and Regulatory 24
Apr 13, 2017: Fresenius Kabi Files Amicus Brief in Arkansas 24
Government and Public Interest 25
Nov 17, 2017: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls 25
Product News 27
Aug 18, 2016: Fresenius Kabi Launches Smoflipid in the United States 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fresenius Kabi USA LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2011 to YTD 2017 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 13
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 14
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 15
APP Pharma Enters Into Licensing Agreement With Teva Pharma For Gemcitabine HCI 16
Fresenius Kabi USA LLC, Key Competitors 17
Fresenius Kabi USA LLC, Key Employees 18
Fresenius Kabi USA LLC, Other Locations 19
Fresenius Kabi USA LLC, Subsidiaries 19

★海外企業調査レポート[Fresenius Kabi USA LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celgene Corporation:企業の戦略・SWOT・財務情報
    Celgene Corporation - Strategy, SWOT and Corporate Finance Report Summary Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Clariant Chemicals (India) Limited (CLNINDIA):企業の財務・戦略的SWOT分析
    Clariant Chemicals (India) Limited (CLNINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • EchoStar Corporation:企業の戦略・SWOT・財務情報
    EchoStar Corporation - Strategy, SWOT and Corporate Finance Report Summary EchoStar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Alize Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alize Pharma SAS (Alize Pharma), a subsidiary of Jazz Pharmaceuticals Plc is a biotechnology company that discovers and develops proteins, biopharmaceutical drugs and peptides. The company provides unacylated ghrelin analog programs that develops stabilized peptide analog of unacylated ghrel …
  • Absa Bank Ltd:企業の戦略・SWOT・財務分析
    Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • AKB Rosbank:企業の戦略・SWOT・財務情報
    AKB Rosbank - Strategy, SWOT and Corporate Finance Report Summary AKB Rosbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vestagen Protective Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Vestagen Protective Technologies Inc (Vestagen), formerly Vestagen Technical Textiles Inc, is a medical technology company. The company develops, manufactures and markets textile products and technologies for uniforms and other apparel for specialty healthcare workers, patients and other occ …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Heartland Consumers Power District:企業の戦略的SWOT分析
    Heartland Consumers Power District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Vallourec Sa:企業の戦略・SWOT・財務分析
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Slovenske elektrarne, a.s.-エネルギー分野:企業M&A・提携分析
    Summary Slovenske elektrarne, a.s. (Slovenske), is an electric utility company that generates, distributes and trades electricity. It also generates and markets heat and offers ancillary services to the power industry. The company generates electricity through various resources such as conventional …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mendor Oy-製薬・医療分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • ProterixBio Inc-医療機器分野:企業M&A・提携分析
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc is a medical device company that manufactures and markets the ViBE platform products. The company offers ViBE platform, acoustic assays; ViBE software and custom assays. Its ViBE platform enables non-optical detection and sensitive quantit …
  • Clay Electric Cooperative Inc:企業の戦略的SWOT分析
    Clay Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆